APO RESEARCH · REPORT
1-Butyl-2-Methylimidazole
1-Butyl-2-Methylimidazole is a heterocyclic chemical substance identified by its named ring and substituent structure.

Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-2-Methylimidazole. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 1-Butyl-2-Methylimidazole?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-2-Methylimidazole. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Industry Research
1-Butyl-2-Methylimidazole Industry Research Report 2026
Market perspective
The global 1-Butyl-2-Methylimidazole market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 1-Butyl-2-Methylimidazole is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 1-Butyl-2-Methylimidazole is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 1-Butyl-2-Methylimidazole is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 1-Butyl-2-Methylimidazole include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 1-Butyl-2-Methylimidazole market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 1-Butyl-2-Methylimidazole.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
1-Butyl-2-Methylimidazole Market by Company
Manus Aktteva Biopharma LLP
Jiangxi Jinkai Chemical Co.,Ltd
IoLiTec
1-Butyl-2-Methylimidazole Segment by Type
Above 98%
Others
1-Butyl-2-Methylimidazole Segment by Application
Chemical Intermediate
Others
1-Butyl-2-Methylimidazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1-Butyl-2-Methylimidazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 1-Butyl-2-Methylimidazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1-Butyl-2-Methylimidazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 1-Butyl-2-Methylimidazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 1-Butyl-2-Methylimidazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 1-Butyl-2-Methylimidazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Others
Applications
- Chemical Intermediate
- Others
Companies covered
- Manus Aktteva Biopharma LLP
- Jiangxi Jinkai Chemical Co.,Ltd
- IoLiTec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 1-Butyl-2-Methylimidazole by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Above 98%
- 2.2.3 Others
- 2.3 1-Butyl-2-Methylimidazole by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chemical Intermediate
- 2.3.3 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global 1-Butyl-2-Methylimidazole Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global 1-Butyl-2-Methylimidazole Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global 1-Butyl-2-Methylimidazole Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 1-Butyl-2-Methylimidazole Production by Manufacturers (2021-2026)
- 3.2 Global 1-Butyl-2-Methylimidazole Production Value by Manufacturers (2021-2026)
- 3.3 Global 1-Butyl-2-Methylimidazole Average Price by Manufacturers (2021-2026)
- 3.4 Global 1-Butyl-2-Methylimidazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 1-Butyl-2-Methylimidazole Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global 1-Butyl-2-Methylimidazole Manufacturers, Product Type & Application
- 3.7 Global 1-Butyl-2-Methylimidazole Manufacturers Established Date
- 3.8 Global 1-Butyl-2-Methylimidazole Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Manus Aktteva Biopharma LLP
- 4.1.1 Manus Aktteva Biopharma LLP 1-Butyl-2-Methylimidazole Company Information
- 4.1.2 Manus Aktteva Biopharma LLP 1-Butyl-2-Methylimidazole Business Overview
- 4.1.3 Manus Aktteva Biopharma LLP 1-Butyl-2-Methylimidazole Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Manus Aktteva Biopharma LLP Product Portfolio
- 4.1.5 Manus Aktteva Biopharma LLP Recent Developments
- 4.2 Jiangxi Jinkai Chemical Co.,Ltd
- 4.2.1 Jiangxi Jinkai Chemical Co.,Ltd 1-Butyl-2-Methylimidazole Company Information
- 4.2.2 Jiangxi Jinkai Chemical Co.,Ltd 1-Butyl-2-Methylimidazole Business Overview
- 4.2.3 Jiangxi Jinkai Chemical Co.,Ltd 1-Butyl-2-Methylimidazole Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Jiangxi Jinkai Chemical Co.,Ltd Product Portfolio
- 4.2.5 Jiangxi Jinkai Chemical Co.,Ltd Recent Developments
- 4.3 IoLiTec
- 4.3.1 IoLiTec 1-Butyl-2-Methylimidazole Company Information
- 4.3.2 IoLiTec 1-Butyl-2-Methylimidazole Business Overview
- 4.3.3 IoLiTec 1-Butyl-2-Methylimidazole Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 IoLiTec Product Portfolio
- 4.3.5 IoLiTec Recent Developments
5 Global 1-Butyl-2-Methylimidazole Production by Region
- 5.1 Global 1-Butyl-2-Methylimidazole Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global 1-Butyl-2-Methylimidazole Production by Region: 2021-2032
- 5.2.1 Global 1-Butyl-2-Methylimidazole Production by Region: 2021-2026
- 5.2.2 Global 1-Butyl-2-Methylimidazole Production Forecast by Region (2027-2032)
- 5.3 Global 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global 1-Butyl-2-Methylimidazole Production Value by Region: 2021-2032
- 5.4.1 Global 1-Butyl-2-Methylimidazole Production Value by Region: 2021-2026
- 5.4.2 Global 1-Butyl-2-Methylimidazole Production Value Forecast by Region (2027-2032)
- 5.5 Global 1-Butyl-2-Methylimidazole Market Price Analysis by Region (2021-2026)
- 5.6 Global 1-Butyl-2-Methylimidazole Production and Value, YOY Growth
- 5.6.1 North America 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts (2021-2032)
6 Global 1-Butyl-2-Methylimidazole Consumption by Region
- 6.1 Global 1-Butyl-2-Methylimidazole Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global 1-Butyl-2-Methylimidazole Consumption by Region (2021-2032)
- 6.2.1 Global 1-Butyl-2-Methylimidazole Consumption by Region: 2021-2026
- 6.2.2 Global 1-Butyl-2-Methylimidazole Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global 1-Butyl-2-Methylimidazole Production by Type (2021-2032)
- 7.1.1 Global 1-Butyl-2-Methylimidazole Production by Type (2021-2032) & (t)
- 7.1.2 Global 1-Butyl-2-Methylimidazole Production Market Share by Type (2021-2032)
- 7.2 Global 1-Butyl-2-Methylimidazole Production Value by Type (2021-2032)
- 7.2.1 Global 1-Butyl-2-Methylimidazole Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global 1-Butyl-2-Methylimidazole Production Value Market Share by Type (2021-2032)
- 7.3 Global 1-Butyl-2-Methylimidazole Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global 1-Butyl-2-Methylimidazole Production by Application (2021-2032)
- 8.1.1 Global 1-Butyl-2-Methylimidazole Production by Application (2021-2032) & (t)
- 8.1.2 Global 1-Butyl-2-Methylimidazole Production Market Share by Application (2021-2032)
- 8.2 Global 1-Butyl-2-Methylimidazole Production Value by Application (2021-2032)
- 8.2.1 Global 1-Butyl-2-Methylimidazole Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global 1-Butyl-2-Methylimidazole Production Value Market Share by Application (2021-2032)
- 8.3 Global 1-Butyl-2-Methylimidazole Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 1-Butyl-2-Methylimidazole Value Chain Analysis
- 9.1.1 1-Butyl-2-Methylimidazole Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 1-Butyl-2-Methylimidazole Production Mode & Process
- 9.2 1-Butyl-2-Methylimidazole Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 1-Butyl-2-Methylimidazole Distributors
- 9.2.3 1-Butyl-2-Methylimidazole Customers
10 Global 1-Butyl-2-Methylimidazole Analyzing Market Dynamics
- 10.1 1-Butyl-2-Methylimidazole Industry Trends
- 10.2 1-Butyl-2-Methylimidazole Industry Drivers
- 10.3 1-Butyl-2-Methylimidazole Industry Opportunities and Challenges
- 10.4 1-Butyl-2-Methylimidazole Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst